Axe Compute P/B

Mitä Axe Compute tekee? Axe Compute Inc, with ticker AGPU and ISIN US74039M4087, is a company based in Eagan, United States, operating within the Health Care sector. The company has 13 employees and went public via an IPO on December 18, 2009. Its website is listed as http://www.precisiontherapeutics.com. The company is engaged in the application of artificial intelligence in medicine, focusing on the development of the STREAMWAY System for automated medical fluid disposal. The STREAMWAY System is designed for direct-to-drain disposal of medical fluids, including blood and irrigation fluids, within medical facilities. The company operates through subsidiaries including Helomics Holding Corporation, TumorGenesis Inc., Skyline Europe, and Skyline Medical Inc. Helomics applies artificial intelligence to patient tumor data to personalize cancer therapies and develop new-targeted therapies. It operates a CLIA-certified laboratory providing clinical testing to assist oncologists in individualizing patient treatment decisions. TumorGenesis Inc. is involved in laboratory-based approaches to tumor development. Skyline Medical Inc. markets the STREAMWAY System, which automates the collection, measurement, and disposal of waste fluids in medical facilities through domestic and international divisions. The company's focus on AI-driven solutions in healthcare positions it within the health care industry, leveraging technology to improve patient outcomes and streamline medical processes. Axe Compute on yksi Eurpooliin suosituimmista yhtiöistä.